Overall, this part of the data further revealed that exosomes derived from CAFs, which is basically consistent with CAFs, also could enhance tumour growth and chemoresistance of NSCLC cells, and activate PI3K/AKT pathway in vivo. The gene discussed is AKT1; the disease is non-small cell lung carcinoma.